Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,685 | 90,172 | 37,403 | 70,698 | 58,734 |
| Marketable Securities | 0 | N/A | N/A | 25,940 | 25,485 |
| Receivables | 7,224 | 5,000 | N/A | N/A | 215 |
| TOTAL | $151,343 | $96,667 | $42,076 | $98,680 | $86,816 |
| Non-Current Assets | |||||
| PPE Net | 1,395 | 1,222 | 2,127 | 2,091 | 2,047 |
| Other Non-Current Assets | 12,697 | 1,680 | 279 | 329 | 438 |
| TOTAL | $14,092 | $2,902 | $2,406 | $2,420 | $2,485 |
| Total Assets | $165,435 | $99,569 | $44,482 | $101,100 | $89,301 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 18,905 | 21,385 | N/A | 4,067 |
| Accounts payable and accrued liabilities | 443 | 500 | 1,100 | 1,606 | 3,882 |
| Accrued Expenses | 8,146 | 13,492 | 11,700 | 8,580 | 3,921 |
| TOTAL | $81,547 | $34,943 | $35,144 | $10,973 | $13,706 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,793 | 0 | N/A | 21,042 | 7,977 |
| Deferred Revenues | 72,050 | 1,674 | 959 | 787 | 1,836 |
| Other Non-Current Liabilities | 38,355 | 41,549 | 938 | 1,201 | 0 |
| TOTAL | $101,894 | $56,229 | $14,756 | $38,313 | $20,638 |
| Total Liabilities | $183,441 | $91,172 | $49,900 | $49,286 | $34,344 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,742 | 2,878 | 1,490 | 744 | 615 |
| Common Shares | 11 | 9 | 3 | 3 | 1 |
| Retained earnings | -404,629 | -335,753 | -280,403 | -216,897 | -151,576 |
| Other shareholders' equity | -4,563 | -4,523 | -4,557 | -4,420 | -4,593 |
| TOTAL | $-18,006 | $8,397 | $-5,418 | $51,814 | $54,957 |
| Total Liabilities And Equity | $165,435 | $99,569 | $44,482 | $101,100 | $89,301 |